[Multicenter randomized double-blind study of triamcinolone hexacetonide versus chymopapain in the treatment of disk lumbosciatica. Initial results at 6 months].
Bourgeois
P
P
Clinique de Rhumatologie, Université de Paris VII, Hôpital Bichat.
Benoist
M
M
Palazzo
E
E
Belmatoug
N
N
Folinais
D
D
Frot
B
B
Busson
G
G
Lassale
P
P
Montagner
C
C
Binoche
T
T
D000328:Adult; D001416:Back Pain / Q000188:drug therapy* / Q000209:etiology; D002917:Chymopapain / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D007405:Intervertebral Disc Displacement / Q000150:complications; D008159:Lumbar Vertebrae; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011897:Random Allocation; D012585:Sciatica / Q000188:drug therapy* / Q000209:etiology; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*
D002917:Chymopapain; D014222:Triamcinolone Acetonide
Etude en double aveugle randomisée multicentrique de l'hexacétonide de triamcinolone versus chymopapaïne dans le traitement de la lombosciatique discale. Premiers résultats à six mois.